Medication Information Leaflet
Febuxostat belongs to a class of medicines called xanthine oxidase inhibitor. It is used for reducing uric acid (also known as urate) levels, stopping crystal formation and dissolving crystals for excretion. Over time, it reduces gout flares and its associated symptoms. Keeping uric acid levels sufficiently low for a long enough period can also shrink tophi (bumps containing urate deposits at the joints).
If you forget to take a dose, take it as soon as you remember. Then take your next dose at the usual time. Do not take two doses to make up for the missed dose.
Inform your healthcare professional if:
Majority of these effects tend to resolve by themselves.
The symptoms of a drug allergy include one or more of the following:
If you experience any of these symptoms, you should stop your medication and see your healthcare professional immediately
Medicines such as Azathioprine, Mercaptopurine, Pegloticase and Theophylline should not be taken together with Febuxostat as they might increase the chance of you experiencing severe side effects. Let your doctor know that you are taking Febuxostat before other medications are prescribed.
Store in a cool and dry place, away from direct sunlight. Keep this medication away from children.
For general waste: Pack this medication into a black trash bag and seal it tightly before throwing into the rubbish chute or bin.
If you take more than the recommended dose, please seek medical advice immediately. The information provided on this page does not replace information from your healthcare professional. Please consult your healthcare professional for more information.
This article is jointly developed by members of the National Medication Information workgroup. The workgroup consists of cluster partners (National Healthcare Group, National University Health System and SingHealth), community pharmacies (Guardian, Unity and Watsons) and Pharmaceutical Society of Singapore. The content does not reflect drug availability and supply information in pharmacies and healthcare institutions. You are advised to check with the respective institutions for such information.
Last updated on Oct 2022
This article was last reviewed on Friday, December 23, 2022